心血管病防治知识(下半月)
心血管病防治知識(下半月)
심혈관병방치지식(하반월)
XINXUEGUANBING FANGZHI ZHISHI
2014年
8期
1-2
,共2页
心血管病%健康体检者%血脂%检验%结果分析
心血管病%健康體檢者%血脂%檢驗%結果分析
심혈관병%건강체검자%혈지%검험%결과분석
Cardiovascular disease%Health examination%Blood lipid%Examination%Result analysis
目的:分析心血管病患者和健康体检者的血脂检验结果。方法选择从2012年10月~2013年10月在本院进行治疗的冠心病患者50例作为观察组,并选择同期在我院进行健康体检者50例作为对照组,对两组血脂水平进行比较。结果观察组患者的HDL-C、APOA-1明显低于对照组,TG、TC、LDL-C、APOB水平明显高于对照组,差异具有显著性(均P<0.05);观察组中,与稳定型心绞痛者相比,不稳定型心绞痛者高脂血症发生率明显较高(P<0.05)。结论心血管疾病与血脂水平有密切联系,血脂检验在心血管疾病的诊断和筛查中具有重要意义,临床应加强对血脂水平的常规监测。
目的:分析心血管病患者和健康體檢者的血脂檢驗結果。方法選擇從2012年10月~2013年10月在本院進行治療的冠心病患者50例作為觀察組,併選擇同期在我院進行健康體檢者50例作為對照組,對兩組血脂水平進行比較。結果觀察組患者的HDL-C、APOA-1明顯低于對照組,TG、TC、LDL-C、APOB水平明顯高于對照組,差異具有顯著性(均P<0.05);觀察組中,與穩定型心絞痛者相比,不穩定型心絞痛者高脂血癥髮生率明顯較高(P<0.05)。結論心血管疾病與血脂水平有密切聯繫,血脂檢驗在心血管疾病的診斷和篩查中具有重要意義,臨床應加彊對血脂水平的常規鑑測。
목적:분석심혈관병환자화건강체검자적혈지검험결과。방법선택종2012년10월~2013년10월재본원진행치료적관심병환자50례작위관찰조,병선택동기재아원진행건강체검자50례작위대조조,대량조혈지수평진행비교。결과관찰조환자적HDL-C、APOA-1명현저우대조조,TG、TC、LDL-C、APOB수평명현고우대조조,차이구유현저성(균P<0.05);관찰조중,여은정형심교통자상비,불은정형심교통자고지혈증발생솔명현교고(P<0.05)。결론심혈관질병여혈지수평유밀절련계,혈지검험재심혈관질병적진단화사사중구유중요의의,림상응가강대혈지수평적상규감측。
Objective To analyze the results of blood lipid test in patients with cardiovascular disease and healthy cases. Methods Fifty patients with coronary heart disease who were treated in our hospital from October 2012 to October 2013 were selected as observation group, and 50 cases who took health examination during the same period in our hospital were selected as control group. Blood lipid levels were compared between the two groups. Results The HDL-C and APOA-1 levels in the observation group were significantly lower than those in the control group (P<0.05), while the TG, TC, LDL-C, and APOB levels were significantly higher than those in the control group (P<0.05). In the observation group, the incidence of hyperlipidemia in patients with unstable angina was significantly higher than that in those with stable angina (P<0.05). Conclusion Cardiovascular disease has a close relationship with blood lipid level, which has a great significance in the diagnosis and screening of this disease, so clinicians should strengthen the routine monitoring of blood lipid level.